CJC 1295 No DAC W/ Ipamorelin

CJC 1295 No DAC W/ Ipamorelin

CJC-1295 No DAC & Ipamorelin Blend | >99% Purity Synergistic Matrix

An advanced dual-peptide formulation designed to target two distinct neuroendocrine pathways for amplified, pulsatile Growth Hormone (GH) release. By combining a GHRH analogue (CJC-1295 No DAC) with a selective GHSR agonist (Ipamorelin), this blend achieves a synergistic elevation of GH and IGF-1 that exceeds the sum of its individual parts.

  • Purity: >99% independently verified via HPLC/MS for both constituent peptides.

  • Dual-Pathway Action: CJC-1295 No DAC amplifies GH pulse magnitude while Ipamorelin initiates the pulse and suppresses somatostatin without elevating cortisol or prolactin.

  • Research Focus: Investigated for synergistic endocrine amplification, rapid lipid metabolism, and optimized slow-wave sleep architecture.

  • The BioRegen Standard: Doctor-reviewed specifications and physically stocked in the USA for rapid laboratory delivery.

Strictly for laboratory and research purposes only.

$1.00

CJC-1295 No DAC & Ipamorelin Blend Research-Grade Synergistic GH Secretagogue Blend

Product Overview

The combination of CJC-1295 No DAC (also known as Modified GRF 1-29) and Ipamorelin represents one of the most advanced, synergistic dual-peptide formulations in neuroendocrine research. This blend is specifically engineered to target two distinct cellular receptors simultaneously, resulting in a drastically amplified, yet naturally pulsatile, release of Growth Hormone (GH).

CJC-1295 No DAC (Modified GRF 1-29) is a synthetic, 29-amino acid analogue of Growth Hormone-Releasing Hormone (GHRH). It features four specific amino acid substitutions that prevent rapid enzymatic cleavage by DPP-IV, extending its half-life to approximately 30 minutes (compared to the 5-minute half-life of standard Sermorelin). It binds directly to the GHRH receptor in the pituitary to stimulate GH synthesis and release.

Ipamorelin is a highly selective pentapeptide that acts as a Growth Hormone Secretagogue Receptor (GHSR) agonist, mimicking the endogenous hormone ghrelin. It acts rapidly to initiate a massive GH pulse while simultaneously suppressing somatostatin (the hormone responsible for halting GH release). Uniquely, Ipamorelin accomplishes this without elevating cortisol or prolactin levels.

When administered together in research models, Ipamorelin forces the release of stored GH while blocking somatostatin, and CJC-1295 No DAC amplifies the magnitude of that release. This dual-pathway approach produces a synergistic GH and IGF-1 elevation that is mathematically greater than the sum of its parts, all while preserving the biological integrity of the body’s natural negative feedback loop.

Primary Research Applications

Under doctor-reviewed scientific literature, the CJC-1295 No DAC & Ipamorelin blend is frequently utilized in in vitro and animal model studies to observe:

  • Synergistic Endocrine Amplification: Investigating the maximization of pulsatile Growth Hormone and IGF-1 secretion through simultaneous GHRH and GHSR receptor activation.

  • Body Composition & Lipid Metabolism: Observing the rapid mobilization of visceral adiposity, enhanced lipolysis, and the simultaneous preservation of lean muscle tissue.

  • Musculoskeletal Repair: Tracking the acceleration of cellular turnover, collagen synthesis, and recovery of injured muscle, tendon, and bone tissues.

  • Sleep Architecture Optimization: Measuring the deepening of slow-wave (delta) sleep patterns, which naturally synchronizes with the induced nocturnal GH pulses.

The BioRegen Standard

When you source your CJC-1295 No DAC & Ipamorelin Blend from BioRegen Peptides, you are backed by our five core pillars of quality and service:

  • Uncompromising Purity: Every batch is independently third-party tested to guarantee >99% purity and molecular integrity, ensuring your dual-pathway models are exact and uncontaminated.

  • Doctor-Reviewed Accuracy: All product specifications and research handling guidelines are medically reviewed for absolute scientific accuracy.

  • Unbeatable Value: Premium, verified research compounds at industry-disrupting prices.

  • Fast, US-Based Shipping: Stocked physically in the USA to bypass customs delays and arrive at your lab in days.

  • Dedicated Support: Have a question about a batch-specific COA? Email our US-based team at support@bioregenpeptides.com for a rapid response.

Product Specifications

  • Nomenclature: CJC-1295 without DAC (Modified GRF 1-29) / Ipamorelin Acetate

  • Amino Acid Sequences: * CJC-1295 No DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

    • Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2

  • CAS Numbers: 863288-34-0 (CJC-1295 No DAC) / 170851-70-4 (Ipamorelin)

  • Molecular Formulas: C152H252N44O42 (CJC-1295 No DAC) / C38H49N9O5 (Ipamorelin)

  • Purity: >99% (Verified via HPLC/MS for both compounds)

  • Format: Lyophilized Powder

Regulatory Notice: This product is sold strictly for laboratory and research purposes only. It is not intended for human consumption, diagnostic, therapeutic, or prophylactic use. Please refer to our doctor-reviewed handling guidelines for proper research protocols.

Related products